These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 28920989)
1. Half sandwich Ru(ii)-acylthiourea complexes: DNA/HSA-binding, anti-migration and cell death in a human breast tumor cell line. Colina-Vegas L; Luna-Dulcey L; Plutín AM; Castellano EE; Cominetti MR; Batista AA Dalton Trans; 2017 Oct; 46(38):12865-12875. PubMed ID: 28920989 [TBL] [Abstract][Full Text] [Related]
2. Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation. Cunha BN; Luna-Dulcey L; Plutin AM; Silveira RG; Honorato J; Cairo RR; de Oliveira TD; Cominetti MR; Castellano EE; Batista AA Inorg Chem; 2020 Apr; 59(7):5072-5085. PubMed ID: 32208661 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of ruthenium-N,N-disubstituted-N'-acylthioureas complexes. de Oliveira TD; Plutín AM; Luna-Dulcey L; Castellano EE; Cominetti MR; Batista AA Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111106. PubMed ID: 32600709 [TBL] [Abstract][Full Text] [Related]
5. Similarities and differences in d Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765 [TBL] [Abstract][Full Text] [Related]
6. Ru(II)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells. Oliveira KM; Honorato J; Gonçalves GR; Cominetti MR; Batista AA; Correa RS Dalton Trans; 2020 Sep; 49(36):12643-12652. PubMed ID: 32870224 [TBL] [Abstract][Full Text] [Related]
7. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets. Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850 [TBL] [Abstract][Full Text] [Related]
8. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis. Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells. Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246 [TBL] [Abstract][Full Text] [Related]
10. Development of novel ruthenium(II)-arene complexes displaying potent anticancer effects in glioblastoma cells. Kumar P; Mondal I; Kulshreshtha R; Patra AK Dalton Trans; 2020 Oct; 49(38):13294-13310. PubMed ID: 32936191 [TBL] [Abstract][Full Text] [Related]
11. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7). Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726 [TBL] [Abstract][Full Text] [Related]
12. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes. Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406 [TBL] [Abstract][Full Text] [Related]
13. Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity. Čanović P; Simović AR; Radisavljević S; Bratsos I; Demitri N; Mitrović M; Zelen I; Bugarčić ŽD J Biol Inorg Chem; 2017 Oct; 22(7):1007-1028. PubMed ID: 28695374 [TBL] [Abstract][Full Text] [Related]
14. Lipophilicity-dependent ruthenium N-heterocyclic carbene complexes as potential anticancer agents. Lv G; Guo L; Qiu L; Yang H; Wang T; Liu H; Lin J Dalton Trans; 2015 Apr; 44(16):7324-31. PubMed ID: 25797411 [TBL] [Abstract][Full Text] [Related]
15. Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η Poljarević JM; Tamás Gál G; May NV; Spengler G; Dömötör O; Savić AR; Grgurić-Šipka S; Enyedy ÉA J Inorg Biochem; 2018 Apr; 181():74-85. PubMed ID: 29407910 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex. Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172 [TBL] [Abstract][Full Text] [Related]